Next 10 |
2024-04-28 12:05:00 ET More on Definitive Healthcare: Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25 Definitive Healthcare Corp. 2023 Q4 - Results - Earnings Call Presentation Definitive Healthcare Corp. (DH) Q4 2023 Earnings Call T...
2024-04-10 12:56:01 ET More on Certara, GoodRx Holdings, etc. GoodRx Holdings: Large TAM Continues To Support Growth Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment Wel...
2024-04-03 00:18:19 ET Summary Phreesia is expected to continue growing revenue at a rate of 20%+ and see an increase in adjusted EBITDA margin as the business scales. PHR has shown strong customer additions, driving revenue growth, and has added new products to contribute to reve...
2024-03-24 23:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-19 07:25:25 ET More on Phreesia Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth Phreesia Q4 2024 Earnings Preview Seeking Alpha’s Quant Rating on Phr...
Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer. Callahan previously served as Phreesia’s Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has be...
2024-03-14 21:01:06 ET Phreesia, Inc. (PHR) Q4 2024 Results Conference Call March 14, 2024 05:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Ryan Daniels - William B...
2024-03-14 16:11:56 ET More on Phreesia Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth Phreesia Q4 2024 Earnings Preview Seeking Alpha’s Quant Rating on Phr...
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024. "Phreesia ended fiscal year 2024 with strong momentum going into fiscal 2025. We facilitated more than 150 million pat...
2024-03-14 11:17:45 ET More on Definitive Healthcare: Definitive Healthcare Corp. 2023 Q4 - Results - Earnings Call Presentation Definitive Healthcare Corp. (DH) Q4 2023 Earnings Call Transcript Definitive Healthcare reports Q4 results Definitive Healthcare's...
News, Short Squeeze, Breakout and More Instantly...
Phreesia Inc Company Name:
PHR Stock Symbol:
NYSE Market:
2024-03-24 23:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer. Callahan previously served as Phreesia’s Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has be...
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024. "Phreesia ended fiscal year 2024 with strong momentum going into fiscal 2025. We facilitated more than 150 million pat...